Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Kobedog is not AngelaL please do not confuse

<< Previous

Bullboard Posts

Next >>

Comment by Dude51on Oct 28, 2021 6:33pm

94 Views

Post# 34061084

RE:Kobedog is not AngelaL please do not confuse

Hey Kobedog1 yes it sucks to have to sell. You can not fall in love with a stock and some do. I sold at 32 and took a shitt kicking after holding for over two years. I then jumped into SONA and lost again. I then bought into THRM which was SONA's main competitor. It still has potential, check it out. It had a good drop today because it looks like we have to wait another 2 or three weeks for the good news, (wink wink who knows, like FDA approval). It could happen, that's all I am saying.
Oh, one last thing, to the manager of Claratas Investors website, bite me Drew, assole. Sorry I digressed. Good luck to everyone else.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario